Are you Dr. Payne?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 54 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
124 Sunset Ct
West Columbia, SC 29169Phone+1 803-931-0077Fax+1 803-931-0076
Summary
- Dr. John Payne, MD is a board certified ophthalmologist in West Columbia, South Carolina. He is currently licensed to practice medicine in South Carolina and Georgia. He is affiliated with Prisma Health Baptist Hospital.
Education & Training
- Emory University School of MedicineResidency, Ophthalmology, 2007 - 2010
- Medical University of South Carolina College of MedicineInternship, Transitional Year, 2006 - 2007
- Medical University of South CarolinaClass of 2006
Certifications & Licensure
- SC State Medical License 2012 - 2025
- GA State Medical License 2009 - 2013
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012
Clinical Trials
Publications & Presentations
PubMed
- 11 citationsLong-term outcomes of treat-and-extend ranibizumab with and without navigated laser for diabetic macular oedema: TREX-DME 3-year results.John F. Payne, Charles C. Wykoff, W. Lloyd Clark, Beau B. Bruce, David S. Boyer
The British Journal of Ophthalmology. 2021-02-01 - 42 citationsRandomized Trial of Treat and Extend Ranibizumab With and Without Navigated Laser Versus Monthly Dosing for Diabetic Macular Edema: TREX-DME 2-Year Outcomes.John F. Payne, Charles C. Wykoff, W. Lloyd Clark, Beau B. Bruce, David S. Boyer
American Journal of Ophthalmology. 2019-06-01 - 6 citationsTopographic Correspondence of Macular Atrophy With Choroidal Neovascularization in Ranibizumab-treated Eyes of the TREX-AMD Trial.Nizar Saleh Abdelfattah, Amir H Hariri, Mayss Al-Sheikh, Sean Pitetta, Adel Ebraheem
American Journal of Ophthalmology. 2018-08-01